Are you Dr. Laquer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 45 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
118 Med Surge I
Irvine, CA 92697Phone+1 949-824-4405Fax+1 949-824-7454
Summary
- Dr. Vivian Laquer, MD is a board certified dermatologist in Irvine, California. She is currently licensed to practice medicine in California. She is affiliated with MemorialCare, Orange Coast Memorial Medical Center and UCI Health.
Education & Training
University of California (Irvine)Residency, Dermatology, 2013 - 2017
Los Angeles County-Harbor-UCLA Medical CenterInternship, Internal Medicine, 2009 - 2010
Columbia University Vagelos College of Physicians and SurgeonsClass of 2009
Certifications & Licensure
CA State Medical License 2010 - 2025- American Board of Dermatology Dermatology
Clinical Trials
- A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis Start of enrollment: 2019 Feb 12
Publications & Presentations
PubMed
- 31 citationsLong-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial.Andrew Blauvelt, Richard G Langley, Jean-Philippe Lacour, Darryl Toth, Vivian Laquer
Journal of the American Academy of Dermatology. 2022-10-01 - 8 citationsSafety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials.Linda Stein Gold, Diamant Thaçi, Jacob P Thyssen, Melinda Gooderham, Vivian Laquer
American Journal of Clinical Dermatology. 2023-07-01 - 7 citationsInterleukin-33 antibody failed to demonstrate benefit in a phase II, double-blind, randomized, placebo-controlled study in adult patients with moderate-to-severe atopi...Vivian Laquer, Viviana Parra, Jean-Philippe Lacour, Hidetoshi Takahashi, Jack Knorr
The British Journal of Dermatology. 2022-10-01
